Chemomab Therapeutics Ltd. Proceeds from Issuance of Debt
Chemomab Therapeutics Ltd. (CMMB) reported Proceeds from Issuance of Debt of $4.05 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2020-03-17
- Chemomab Therapeutics Ltd. proceeds from issuance of debt for fiscal 2018 was $4.05M.
| Period end | Proceeds from Issuance of Debt 12 month |
|---|---|
| 2018-12-31 | $4.05M 10-K · filed 2020-03-17 |